Clearmind Medicine (CMND) Receivables - Other (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Receivables - Other of $405315.0 for Q2 2026, up 195.76% year-over-year from $137042.0 in Q2 2025, and up 27.54% quarter-over-quarter from $317783.0 in Q1 2026.
Clearmind Medicine (CMND) Receivables - Other (2022 - 2026) Analysis & Trends
Clearmind Medicine's Receivables - Other history runs 5 years deep, the most recent figure standing at $405315.0 for Q2 2026.
- In Q2 2026, Receivables - Other rose 195.76% year-over-year to $405315.0; the TTM figure through Apr 2026 stood at $405315.0 (up 195.76% YoY), while the FY2025 annual figure was $286488.0, up 117.3% from the prior year.
- Receivables - Other for Q2 2026 stood at $405315.0, up from $317783.0 in the prior quarter.
- The five-year high for Receivables - Other was $405315.0 in Q2 2026, with the low at -$100197.0 in Q2 2023.
- The 5-year median for Receivables - Other is $134440.5 (2024), against an average of $160678.9.
- The sharpest annual moves came in 2023 and 2024: Receivables - Other soared 493.31% in 2023, then plunged 53.98% in 2024.
- Clearmind Medicine's Receivables - Other stood at $48286.2 in 2022, then jumped by 493.31% to $286488.0 in 2023, then slumped by 53.98% to $131839.0 in 2024, then surged by 117.3% to $286488.0 in 2025, then soared by 41.48% to $405315.0 in 2026.
- Business Quant data shows CMND's Receivables - Other at $405315.0 in Q2 2026, $317783.0 in Q1 2026, and $286488.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 405,315.00 |
| Apr 30, 2026 | 405,315.00 |
| Jan 31, 2026 | 317,783.00 |
| Jan 31, 2026 | 317,783.00 |
| Oct 31, 2025 | 286,488.00 |
| Oct 31, 2025 | 286,488.00 |
| Jul 31, 2025 | 174,043.00 |
| Jul 31, 2025 | 174,043.00 |
| Apr 30, 2025 | 137,042.00 |
| Apr 30, 2025 | 137,042.00 |
| Jan 31, 2025 | 143,490.00 |
| Jan 31, 2025 | 143,490.00 |
| Oct 31, 2024 | 131,839.00 |
| Oct 31, 2024 | 131,839.00 |
| Jul 31, 2024 | 108,597.00 |
| Jul 31, 2024 | 108,597.00 |
| Apr 30, 2024 | 105,022.00 |
| Apr 30, 2024 | 105,022.00 |
| Jan 31, 2024 | 85,382.00 |
| Jan 31, 2024 | 85,382.00 |